isoborneol has been researched along with Lung Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, D; Li, J; Li, Y; Lu, D; Ma, R; Ren, M; Wang, J; Xie, Q; Xu, Z; Yuan, J | 1 |
| Li, J; Li, Y; Lu, D; Ma, R; Ren, M; Wang, J; Xie, Q; Xu, Z; Yuan, J | 1 |
| Chan, L; Chen, T; He, D; Huang, Y; Yuan, R | 1 |
| Bodempudi, V; Dudek, AZ; Galvez, J; Isaksson Vogel, R; Jasinski, P; Land, D; Terai, K; Zwolak, P | 1 |
| Bodenmiller, D; Fitch, RW; Jalal, SI; Neher, TM; Turchi, JJ | 1 |
5 other study(ies) available for isoborneol and Lung Neoplasms
| Article | Year |
|---|---|
d-Borneol enhances cisplatin sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis in non-small cell lung cancer cells and a murine xenograft model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camphanes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Heterografts; Humans; Lung Neoplasms; Mice; Xenograft Model Antitumor Assays | 2022 |
d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy.
Topics: Autophagy; Beclin-1; Cadherins; Camphanes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Epithelial-Mesenchymal Transition; Fluorescent Dyes; Glutathione; Heme Oxygenase-1; Humans; Iron; Lung Neoplasms; Malondialdehyde; Nuclear Receptor Coactivators; Reactive Oxygen Species; RNA; RNA-Binding Proteins; Superoxide Dismutase; Thioredoxins; Transcription Factors; Vimentin | 2022 |
Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camphanes; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cells, Cultured; Drug Screening Assays, Antitumor; Emulsions; Female; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Particle Size; Surface Properties; Vesicular Transport Proteins | 2020 |
MT103 inhibits tumor growth with minimal toxicity in murine model of lung carcinoma via induction of apoptosis.
Topics: Administration, Oral; Animals; Apoptosis; Camphanes; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Lung Neoplasms; Lymphatic Metastasis; Mice; Protein Kinase C; Sulfonamides; Survival Analysis; Time Factors; Xenograft Model Antitumor Assays | 2011 |
Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camphanes; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA Damage; DNA Replication; DNA, Neoplasm; DNA, Single-Stranded; Drug Synergism; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Replication Protein A; Small Molecule Libraries | 2011 |